XTRA LIGHTENING COKTAIL

5 bottles of 5 ml

Anti-spot clarifying agent with peptides

XTRA Lightening works by reducing melanin synthesis, age spots and freckles.

XTRA Lightening provides a clarifying, lightening, homogenizing and depigmenting effect on the skin, restoring vitality, luminosity and transparency.

Using XTRA Lightening:

• 8 to 12 mesotherapy sessions spaced one week apart

Arbutin : Effectively inhibits tyrosinase activity and, therefore, melanin production. Thanks to structural similarities with tyrosinase substrates, arbutin acts following a mechanism of binding competition in the active regions of the enzyme.

Additionally, arbutin has the ability to inhibit the DHICA product Polymerase (5,6-dihydroxy-indole-2-carboxylic acid) resulting from the oxidation of tyrosine.

Glycyrrhiza uralensis (licorice) root extract : inhibition of the tyrosinase enzyme, and a slight action of reduction of melanin and color precursors.

Licorice extract also has anti-inflammatory properties by inhibiting superoxide anion synthesis and cyclooxygenase activity.

Anti-aging effect to effectively absorb UVA and B rays. Anti-free radical.

3-O-ethyl Ascorbic Acid : The depigmenting activity of ascorbic acid is due to both its tyrosinase inhibitory action and its ability to reduce dopaquinone to DOPA, which can also prevent melanin formation.

Cromabright™ : inhibits tyrosinase activity. Significant depigmenting effect in melanocytes. It produces a powerful skin whitening effect in vivo. photoprotective effect on cell cultures of keratinocytes of the human epidermis, acting as a preventative measure against skin lesions induced by ultraviolet radiation.

Pentapeptide-13: With clarification, homogenizing properties of the skin tone.

Antioxidant Decapeptide-15 : Clarification and whitening of the skin.

Prevents photoaging Inhibits melanin synthesis through a mechanism of inhibition of tyrosinase expression.

Oligopeptide-50 : Inhibits melanin synthesis by inhibition of tyrosinase. Changes the morphology of melanocytes. Induces the reduction of melanin synthesis and the formation of melanosomes in melanocytes. Inhibits the expression of the melanogenesis marker.

Oligopeptide-34 : inhibits melanin synthesis. Reduces tyrosinase activity. It produces a decrease in the formation of melanosomes in treated melanocytes.

Oligopeptide-51 inhibits the expression of the melanogenesis marker. It inhibits the synthesis of melanin. Induces morphological changes in melanocytes.

Glutathione: Glutathione has an SH reducing group.

This functional group can form a complex with copper and reducing dopaquinone. Glutathione induces the formation of pheomelanin from dopaquinone